Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb.

Reshef R, Kudryavitskaya E, Shani-Narkiss H, Isaacson B, Rimmerman N, Mizrahi A, Yirmiya R.

Elife. 2017 Dec 18;6. pii: e30809. doi: 10.7554/eLife.30809.

2.

The hippocampal transcriptomic signature of stress resilience in mice with microglial fractalkine receptor (CX3CR1) deficiency.

Rimmerman N, Schottlender N, Reshef R, Dan-Goor N, Yirmiya R.

Brain Behav Immun. 2017 Mar;61:184-196. doi: 10.1016/j.bbi.2016.11.023. Epub 2016 Nov 23.

PMID:
27890560
3.

Depression as a microglial disease.

Yirmiya R, Rimmerman N, Reshef R.

Trends Neurosci. 2015 Oct;38(10):637-658. doi: 10.1016/j.tins.2015.08.001. Review.

PMID:
26442697
4.

Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death.

Rimmerman N, Ben-Hail D, Porat Z, Juknat A, Kozela E, Daniels MP, Connelly PS, Leishman E, Bradshaw HB, Shoshan-Barmatz V, Vogel Z.

Cell Death Dis. 2013 Dec 5;4:e949. doi: 10.1038/cddis.2013.471.

5.

Cannabinoids decrease the th17 inflammatory autoimmune phenotype.

Kozela E, Juknat A, Kaushansky N, Rimmerman N, Ben-Nun A, Vogel Z.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1265-76. doi: 10.1007/s11481-013-9493-1. Epub 2013 Jul 28.

PMID:
23892791
6.

Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells.

Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Gao F, Coppola G, Geschwind D, Vogel Z.

PLoS One. 2013 Apr 24;8(4):e61462. doi: 10.1371/journal.pone.0061462. Print 2013.

7.

Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells.

Juknat A, Rimmerman N, Levy R, Vogel Z, Kozela E.

Neurochem Int. 2012 Nov;61(6):923-30. doi: 10.1016/j.neuint.2011.12.002. Epub 2011 Dec 9.

PMID:
22178458
8.

Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.

Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Coppola G, Geschwind D, Vogel Z.

Br J Pharmacol. 2012 Apr;165(8):2512-28. doi: 10.1111/j.1476-5381.2011.01461.x.

9.

The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.

Rimmerman N, Juknat A, Kozela E, Levy R, Bradshaw HB, Vogel Z.

Cell Mol Neurobiol. 2011 Aug;31(6):921-30. doi: 10.1007/s10571-011-9692-3. Epub 2011 Apr 30.

PMID:
21533611
10.

Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

Rimmerman N, Bradshaw HB, Kozela E, Levy R, Juknat A, Vogel Z.

Br J Pharmacol. 2012 Apr;165(8):2436-49. doi: 10.1111/j.1476-5381.2011.01380.x.

11.

Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.

Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben-Nun A, Juknat A, Vogel Z.

Br J Pharmacol. 2011 Aug;163(7):1507-19. doi: 10.1111/j.1476-5381.2011.01379.x.

12.

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.

McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw HB.

BMC Neurosci. 2010 Mar 26;11:44. doi: 10.1186/1471-2202-11-44.

13.

Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.

Kozela E, Pietr M, Juknat A, Rimmerman N, Levy R, Vogel Z.

J Biol Chem. 2010 Jan 15;285(3):1616-26. doi: 10.1074/jbc.M109.069294. Epub 2009 Nov 12.

14.

Novel endogenous N-acyl glycines identification and characterization.

Bradshaw HB, Rimmerman N, Hu SS, Burstein S, Walker JM.

Vitam Horm. 2009;81:191-205. doi: 10.1016/S0083-6729(09)81008-X. Review.

PMID:
19647113
15.

Differential changes in GPR55 during microglial cell activation.

Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A.

FEBS Lett. 2009 Jun 18;583(12):2071-6. doi: 10.1016/j.febslet.2009.05.028. Epub 2009 May 22.

16.

The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.

Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM.

BMC Biochem. 2009 May 21;10:14. doi: 10.1186/1471-2091-10-14.

17.

Microsomal omega-hydroxylated metabolites of N-arachidonoyl dopamine are active at recombinant human TRPV1 receptors.

Rimmerman N, Bradshaw HB, Basnet A, Tan B, Widlanski TS, Walker JM.

Prostaglandins Other Lipid Mediat. 2009 Jan;88(1-2):10-7. doi: 10.1016/j.prostaglandins.2008.08.004. Epub 2008 Sep 2.

18.

Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain.

Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, Kashman Y, Huang SM, Lee H, Shohami E, Mackie K, Caterina MJ, Walker JM, Fride E, Mechoulam R.

FASEB J. 2008 Aug;22(8):3024-34. doi: 10.1096/fj.07-101865. Epub 2008 May 20.

19.

N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons.

Rimmerman N, Bradshaw HB, Hughes HV, Chen JS, Hu SS, McHugh D, Vefring E, Jahnsen JA, Thompson EL, Masuda K, Cravatt BF, Burstein S, Vasko MR, Prieto AL, O'Dell DK, Walker JM.

Mol Pharmacol. 2008 Jul;74(1):213-24. doi: 10.1124/mol.108.045997. Epub 2008 Apr 18.

20.

Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.

Rimmerman N, Hughes HV, Bradshaw HB, Pazos MX, Mackie K, Prieto AL, Walker JM.

Br J Pharmacol. 2008 Jan;153(2):380-9. Epub 2007 Oct 29.

21.

Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells.

Opitz CA, Rimmerman N, Zhang Y, Mead LE, Yoder MC, Ingram DA, Walker JM, Rehman J.

FEBS Lett. 2007 Oct 16;581(25):4927-31. Epub 2007 Sep 24.

22.

Fatty acyl amides of endogenous tetrahydroisoquinolines are active at the recombinant human TRPV1 receptor.

O'Dell DK, Rimmerman N, Pickens SR, Walker JM.

Bioorg Med Chem. 2007 Sep 15;15(18):6164-9. Epub 2007 Jun 20.

PMID:
17616464
23.

Targeted lipidomics: discovery of new fatty acyl amides.

Tan B, Bradshaw HB, Rimmerman N, Srinivasan H, Yu YW, Krey JF, Monn MF, Chen JS, Hu SS, Pickens SR, Walker JM.

AAPS J. 2006 Jul 14;8(3):E461-5. Review.

24.

Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators.

Bradshaw HB, Rimmerman N, Krey JF, Walker JM.

Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R349-58. Epub 2006 Mar 23.

25.

Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.

Zuckerman L, Rimmerman N, Weiner I.

Psychopharmacology (Berl). 2003 Sep;169(3-4):298-307. Epub 2003 Jun 24.

PMID:
12827344

Supplemental Content

Loading ...
Support Center